SBIO | ALPS Medical Breakthroughs ETF Overview

(Stock Exchange: AMEX)

Day's Range	27.89 - 28.78
52 Week Range	27.97 - 42.73
Beta	0.85
Implied Volatility	34.36%
IV Rank	62.56%
Day's Volume	42,343
Average Volume	11,279
Shares Outstanding	3,174,557
Inception Date	2014-12-31

Assets	119,156,809
Asset Class	Equity
Expense Ratio	0.50
P/E Ratio	N/A
EPS	N/A
Dividend Yield	3.96%
Dividend Per Share	1.13
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

*Chart delayed

Watching at SBIO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SBIO Technicals page.